News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
OraSure Tech (OSUR) Announces 2016 Annual Meeting Date 8/28/2015
OvaScience (OVAS) Reports Promising IVF Alternative, But Still Faces Challenges 8/28/2015
ArisGlobal Announces Autumn 2015 Clinical R&D Webinar Series 8/27/2015
Landauer (LDR) Declares Regular Cash Dividend 8/27/2015
Amarantus BioSciences, Inc. Moves Annual Meeting Date Forward To September 2, 2015 8/27/2015
Golden Meditech Holdings Limited Announces Mr. Kam Acquired & Indirectly Held CO Convertible Notes From KKR 8/27/2015
Great Basin Scientific Announces Intent To Settle Certain Warrant Exercises With Cash 8/27/2015
uniQure (QURE) Announces Financial Results For Second Quarter 2015 8/27/2015
China Cord Blood Corporation Receives Notice Of Transactions Regarding Its 7% Senior Convertible Notes Due 2017 8/26/2015
Polydex Pharmaceuticals (POLXF) Appeals To Shareholders To Participate In Online Voting For AGM 8/26/2015
Intrexon Announces Closing Of $230 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/26/2015
Kewaunee Scientific Corporation Raises Dividend 8% 8/26/2015
Sirona Biochem Announces Results Of Shareholder Meeting 8/26/2015
Great Basin Corporation Confirms Separation Of Publicly Traded Units 8/26/2015
Opko Health (OPK) Letter To Shareholders 8/26/2015
MediciNova, Inc. Announces Closing Of Underwritten Public Offering Of Common Stock 8/25/2015
Celgene (CELG) Announces Expiration Of Cash Tender Offer For Shares Of Receptos (RCPT) 8/25/2015
Price-Point for Amgen (AMGN)'s Anti-Cholesterol Drug Repatha Could be a Sticking Point for Investors 8/24/2015
Benitec (BLT.AX) Announces Closing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/24/2015
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/24/2015
InVivo Therapeutics (NVIV) Announces Listing Transfer To Nasdaq Global Market 8/24/2015
Pernix (PTX) Announces New Revolving Credit Facility 8/24/2015
Affymetrix (Santa Clara, California) (AFFX) Reports New Employee Stock Grants 8/24/2015
Navidea (NAVB) To Register Shares For Dual Listing On Tel-Aviv Stock Exchange 8/24/2015
In the Hot CAR-T Market, Analyst Projects Juno (JUNO) Stock to Double 8/21/2015
Intrexon Announces Proposed Public Offering Of Common Stock 8/21/2015
Marrone Bio Innovations, Inc Announces Completion Of $40 Million Loan Financing; Update On Management And NASDAQ Matters 8/21/2015
Intrexon Prices Public Offering Of Common Stock 8/21/2015
Champions Oncology, Inc. (CSBR) Announces Uplisting To NASDAQ 8/21/2015
Ceres, Inc. Announces Pricing Of $2.1 Million At-The-Market Registered Direct Offering And Private Placement 8/21/2015
Three Biotech Stocks We Absolutely Love 8/20/2015
Eight Things You Probably Don't Know About Johnson & Johnson (JNJ) 8/20/2015
DelMar Pharmaceuticals Completes $2.6 Million Registered Direct Offering 8/20/2015
Depomed (DEPO)'s Board Of Directors Unanimously Rejects Revised Proposal From Horizon Pharma (HZNP) 8/20/2015
Acasti Pharma Announces Grant Of Stock Options 8/20/2015
Karolinska Development AB – Q2 Report - Invitation To Conference Call And Webcast 8/20/2015
Amedica Corporation Granted 180-Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule 8/20/2015
Bionik Laboratories Commences Trading On OTCQX Under Ticker Symbol BNKL 8/19/2015
Accounting Blunders Cost Hanger (HGR) $28 Million 8/19/2015
Hemispherx Biopharma (HEB) Reminder Regarding Stockholder Open House At Manufacturing And Research Facility In New Jersey 8/19/2015
MediciNova, Inc. Announces Proposed Underwritten Public Offering Of Common Stock 8/19/2015
MediciNova, Inc. Announces Pricing Of Underwritten Public Offering Of Common Stock 8/19/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 8/19/2015
Siegfried With Sales Growth And Continued High Earning Power 8/19/2015
Lonza Inc. Prices CHF 325 Million Dual Tranche Straight Bonds 8/19/2015
Targacept (TRGT) Announces Stockholder Approval Of Proposals Related To Merger With Catalyst Biosciences 8/19/2015
Inotek Pharmaceuticals Corporation (ITEK) Announces Closing Of $79.2 Million Public Offering Including Exercise In Full Of Underwriters’ Option To Purchase Additional Shares 8/19/2015
BioSpecifics Technologies Corporation (BSTC) Announces Board Authorization Of Up To $2.5 Million Stock Repurchase Program 8/18/2015
Benitec (BLT.AX) Announces Pricing Of An Initial Public Offering In The United States With Listing On NASDAQ 8/18/2015
INC Research (INCR) Announces Closing Of Secondary Offering 8/18/2015
Catalyst Pharmaceuticals (CPRX) To Ring The Nasdaq Stock Market Closing Bell 8/18/2015
AmpliPhi Biosciences Corporation (APHB) Announces Approval Of Common Stock Listing On NYSE MKT 8/18/2015
Ironwood (IRWD), Aegerion (AEGR), and MannKind Corporation (MNKD) Face Stiff Headwinds: Analyst 8/18/2015
CRH Medical Announces Filing For A US Listing 8/17/2015
PTC Therapeutics (PTCT) Announces Closing Of $150 Million Of Convertible Senior Notes 8/17/2015
Polydex Pharmaceuticals (POLXF) Reminds Shareholders Of Upcoming AGM And New Voting Procedures 8/17/2015
3SBio Inc. (SSRX) Selected As A Constituent Of The Hang Seng Composite LargeCap & MidCap Index 8/17/2015
Tauriga Sciences Inc. (TAUG) Issues Shareholder Update On Status Of Company And Future Strategic Plan 8/17/2015
MYOS (MYOS) To Host Conference Call To Discuss Management Highlights 8/17/2015
MediGene AG (MDGEF.PK) Reports Outcome Of Annual General Meeting 8/14/2015
Mount Tam Biotechnologies Announces Completion Of Share Exchange Transaction 8/14/2015
Suven Life Sciences Ltd’s Income Lower By 7.35%; PAT Up By 19.36% For The Quarter Ended June 2015 8/14/2015
Google (GOOG)'s New Parent Company Alphabet and What It Means for Life Sciences, Calico, and Healthcare 8/13/2015
RedChip Issues Research Update On Cancer Genetics (CGIX) 8/13/2015
BG Medicine (BGMD) Announces Proposed Underwritten Public Offering 8/13/2015
Aytu BioScience Announces Effectiveness Of Resale Registration Of Common Shares For Certain Existing Security Holders 8/13/2015
AMAG (AMAG) Announces Pricing Of Private Offering Of $500 Million Of Senior Notes Due 2023 8/13/2015
Mylan (MYL) Lowers Acceptance Condition On Perrigo (PRGO) Offer To Greater Than 50% 8/13/2015
BioMark Diagnostics Unveils U.S. Strategy 8/13/2015
Mologen AG (MOLGF.PK): First Half Of 2015 Defined By Study Progress And Capital Increase 8/13/2015
LDR (LDRH) Announces Proposed Public Offering Of Common Stock 8/13/2015
LDR (LDRH) Announces Pricing Of Public Offering Of Common Stock 8/13/2015
Pfizer (PFE) Spends $300 Million on Exploring Possibility of Split 8/12/2015
Champions Oncology, Inc. (CSBR) Announces Reverse Stock Split In Preparation For Uplisting To NASDAQ 8/12/2015
Omega Protein Corporation (OME) Receives Letter from Shareholder 8/12/2015
Dermira Announces Closing Of Follow-On Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/12/2015
Aegera Therapeutics Grants Stock Options Under Inducement Program 8/12/2015
IsoRay, Inc. (ISR) Announces Appointment Of PCG Advisory Group As Investor, Public And Digital Communications Agency Of Record 8/12/2015
Cell MedX Corp (CMXC) Enters Into An Option Agreement With Its President And CEO 8/12/2015
INC Research (INCR) Announces Pricing Of Secondary Offering 8/12/2015
AVINTIV Specialty Materials Inc. Announces Exchange Offer For Its 6.875% Senior Notes Due 2019 8/11/2015
Portage Biotech's Biohaven Raises $ 4.1 Million In First Tranche Of Private Placement. Portage Invests $ 2.5 Million 8/11/2015
PTC Therapeutics (PTCT) Announces Intention To Offer Convertible Senior Notes 8/11/2015
PTC Therapeutics (PTCT) Announces Pricing of $125 Million Of Convertible Senior Notes 8/11/2015
Immune Pharmaceuticals, Inc. Announces Corporate Update And Second Quarter 2015 Financial Results Conference Call 8/11/2015
Intuitive Surgical (ISRG) Reports New Employee Option Grants For August 2015 8/11/2015
Discovery Laboratories (DSCO) Provides Business Update And Reports Second Quarter 2015 Financial Results 8/11/2015
Sinovac Biotech Ltd. (SVA) Announces Results Of 2015 Annual General Meeting Of Shareholders 8/11/2015
VolitionRX Announces Second Quarter 2015 Financial Results And Business Update 8/11/2015
Relmada Therapeutics Announces Reverse Stock Split In Preparation For Proposed Uplisting To NASDAQ Capital Market 8/10/2015
Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering 8/10/2015
BioDelivery Sciences International (BDSI) Provides Corporate Update And Reports Second Quarter 2015 Financial Results 8/10/2015
Concord Medical Services Holdings Limited (CCM) Announces Share Repurchase Program 8/10/2015
Amarantus BioSciences, Inc. Announces Adjournment Of Annual Meeting 8/10/2015
ADM Tronics Unlimited (ADMT) Receives Strategic Investment From Advanced Plasma Therapies 8/10/2015
BioScrip (BIOS) Announces Steps To Enhance Shareholder Value 8/10/2015
Zynerba (ZYNE) Announces Closing Of Its Initial Public Offering And Exercise In Full Of Option To Purchase Additional Shares 8/10/2015
MabVax Therapeutics Holdings Provides Corporate Update And Reports Second Quarter 2015 Financial Results 8/10/2015
Cerulean Pharma Inc. (CERU) Reports Second Quarter 2015 Corporate Highlights And Financial Results 8/7/2015
Ocata Therapeutics Provides Corporate Update For The Second Quarter Of 2015 8/7/2015
Cellceutix (CTIX) Comes Out Swinging After Anonymous Seeking Alpha Blog Post 8/7/2015
AMAG (AMAG) Announces Closing Of $231 Million Public Offering Of Common Stock Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/6/2015
Quintiles (Q) Announces Closing Of Secondary Public Offering 8/6/2015
Atrion (ATRI) Increases Quarterly Cash Dividend By 20% 8/6/2015
Bio-Techne (TECH) Declares Dividend 8/6/2015
Corium International, Inc. Prices Follow-On Offering Of Common Stock 8/6/2015
Dermira Prices Follow-On Public Offering Of Common Stock 8/6/2015
GTX Corp Provides Corporate Update And Reports Second Quarter 2015 Financial Results 8/6/2015
Seres Therapeutics Reports Second Quarter 2015 Financial Results And Provides Business Update 8/6/2015
BIND Therapeutics (BIND) Reports Second Quarter 2015 Financial Results And Provides Corporate Update 8/6/2015
AmerisourceBergen Corporation (ABC) Declares Quarterly Dividend 8/6/2015
Infinity Pharmaceuticals Inc. (INFI) Provides Company Update And Reports Second Quarter 2015 Financial Results 8/6/2015
HEALTHSOUTH Announces Pricing Of $350 Million Of Senior Notes In A Private Offering 8/5/2015
Dermira Commences Follow-On Public Offering Of Common Stock 8/5/2015
Flexion (FLXN) Secures $30 Million In Debt Financing 8/5/2015
MabVax Therapeutics, Inc. Issues Letter To Stockholders 8/5/2015
Cara Therapeutics, Inc. (CARA) Announces Closing Of Its Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/5/2015
Relypsa (RLYP) Announces New Employment Inducement Grants 8/5/2015
AMAG (AMAG) Announces Proposed Private Offering Of $450 Million Of Senior Notes Due 2023 8/5/2015
Zogenix (ZGNX) Announces Closing Of Public Offering Of Common Stock, Including Full Exercise Of Underwriters' Option To Purchase Additional Shares 8/5/2015
Mylan (MYL) Provides Update On Conditions To Perrigo (PRGO) Offer 8/5/2015
Targacept (TRGT) Declares Pre-closing Dividend In Connection With Its Merger With Catalyst Biosciences 8/5/2015
AVEO Oncology (AVEO) To Host Midyear Update Conference Call On August 10, 2015 8/5/2015
Great Basin Scientific Announces Business Update Call And Webcast 8/5/2015
Notice of Annual General Meeting In Sectra (SECTB) 8/5/2015
EyeGate Pharma Announces Closing Of Public Offering Of Common Stock And Warrants 8/5/2015
Integra LifeSciences (IART) Prices Public Offering Of Common Stock 8/5/2015
Boston Scientific (BSX) Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 8/4/2015
Emdeon Corporation (HLTH) Announces Offering Of Its Senior Notes Due 2021 8/4/2015
AcelRx (ACRX) Provides Business Update And Reports Second Quarter And Six Months 2015 Financial Results 8/4/2015
HEALTHSOUTH Announces Private Offering Of Senior Notes 8/4/2015
Corium International, Inc. Announces Proposed Public Offering of Common Stock 8/4/2015
Quotient Limited (QTNTU) Expands Existing Term Credit Facility With MidCap Financial to $50 Million 8/4/2015
Integra LifeSciences (IART) Announces Proposed Public Offering Of Common Stock 8/4/2015
Intec Pharma Ltd. Announces Pricing of U.S. Initial Public Offering 8/4/2015
Amarantus BioSciences, Inc. Announces Adjournment Of Annual Meeting 8/4/2015
Mettler-Toledo (MTD) Announces New Process Chemistry And Scale-up Online Seminar 8/4/2015
Genocea Biosciences Announces Closing Of $50 Million Public Offering Of Common Stock 8/4/2015
Celgene (CELG) Prices $8 Billion Of Senior Unsecured Notes 8/4/2015
Lumenis (LUME) Announces Results Of Special Shareholders' Meeting 8/4/2015
AmpliPhi Biosciences Corporation (APHB) Cleared To Submit Listing Application To NYSE MKT 8/4/2015
PTC Therapeutics (PTCT) Reports Second Quarter 2015 Financial Results And Provides Corporate Update 8/3/2015
China Cord Blood Corporation Files Its Annual Report On Form 20-F 8/3/2015
Egalet Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares 8/3/2015
IDEXX Laboratories, Inc. (IDXX) To Host 2015 Analyst Day 8/3/2015
Arbutus Biopharma (TKMR) To Ring The Nasdaq Stock Market Opening Bell 8/3/2015
Bacterin Closes Offering Of $65 Million Of 6.00% Convertible Senior Notes 8/3/2015
Celgene (CELG) Announces Offering Of Senior Unsecured Notes 8/3/2015
Jaguar Holding Company II And Pharmaceutical Product Development, LLC Announce $1,125 Million Senior Notes Offering 8/3/2015
Welcome To The Annual General Meeting Of Shareholders Of Elekta AB (SE:EKTAB) 8/3/2015
Sevion Therapeutics, Inc. Announces Close Of Private Placement Financing For Gross Proceeds Of Approximately $6.55 Million 8/3/2015
Tauriga Sciences Inc. (TAUG) Granted 7 Day Extension By OTC Markets To Maintain Listing On OTCQB Exchange 8/3/2015
Horizon Pharma (HZNP) Commences Process To Request A Special Meeting Of Depomed (DEPO) Shareholders 8/3/2015
AMAG (AMAG) Prices Public Offering Of $201 Million Of Common Stock 7/31/2015
EyeGate Pharma Announces Pricing Of $10,000,000 Public Offering Of Common Stock And Warrants 7/31/2015
Nanosphere, Inc. Announces Amendment to $30 Million Term Loan Facility, Release of Q2 2015 Results and Conference Call and Schedules 2015 Annual Meeting of Stockholders 7/31/2015
Cryo-Cell International (CCEL), Cord Blood Banking Company, Announces Final Results Of Its Tender Offer 7/31/2015
Quintiles (Q) Announces Pricing Of Secondary Public Offering 7/31/2015
Quintiles (Q) Announces Launch Of Secondary Public Offering Of Common Stock 7/31/2015
Newly Appointed Acting CEO Outlines Immediate Plans For Novogen Limited (NVGN) 7/31/2015
Change Of The Number Of Shares And Votes In Karo Bio AB 7/31/2015
Change In Number Of Shares And Votes In Moberg Pharma AB (Formerly known as Moberg Derma) 7/31/2015
Change In The Total Number Of Shares And Votes In Recipharm AB 7/31/2015
Number Of Shares And Votes In Orexo AB (ORXOF) 7/31/2015
Tianyin Pharmaceutical Co, Inc. Provides Update Regarding Non-Compliance With NYSE MKT Continued Listing Requirements 7/31/2015
GlaxoSmithKline (GSK) CEO Confident Investors Will Be Pleased With Pipeline on Nov. R&D Day 7/30/2015
AMAG (AMAG) Announces Proposed Public Offering Of $200 Million Of Common Stock 7/30/2015
Zogenix (ZGNX) Prices Public Offering Of Common Stock 7/30/2015
Zealand Pharma  (ZEAL.CO) Release: Major Shareholder Announcement 7/30/2015
Cara Therapeutics, Inc. (CARA) Announces Pricing Of Its Public Offering Of Common Stocks 7/30/2015
Perseon Announces Pricing Of $5.2 Million Public Offering And Listing Of Warrants On NASDAQ 7/30/2015
SANUWAVE Shareholders Approve Proposal To Amend Articles Of Incorporation 7/30/2015
Pulmatrix To Webcast Investor Presentation And Provide Update On Pipeline Of Inhaled Therapeutics August 6th 7/30/2015
KaloBios Pharmaceuticals, Inc. (KBIO) Regains Compliance With NASDAQ Minimum Bid Price Requirement 7/30/2015
Nasdaq Welcomes vTv Therapeutics Tto The Nasdaq Stock Market 7/30/2015
Genocea Biosciences Announces Pricing Of $50 Million Public Offering 7/30/2015
Inotek Pharmaceuticals Corporation Announces Conversion Of $21 Million Principal Amount Of 5.0% Convertible Senior Notes Due 2020 7/30/2015
McKesson Corporation Declares Quarterly Dividend July 29, 2015 7/30/2015
Baxter International (BAX) Declares Quarterly Dividend 7/30/2015
Teleflex Incorporated (TFX) Announces Quarterly Dividend 7/30/2015
Admedus Announcement To The Australian Stock Exchange 7/30/2015
Biogen (BIIB) Chairman Reassures Investors With $3 Million Stock Buy 7/29/2015
Zogenix (ZGNX) Announces Proposed Public Offering Of 3,800,000 Shares Of Common Stock 7/29/2015
MannKind Corporation (MNKD) Announces Stock And Note Exchange Agreements With Holders Of Outstanding 5.75% Senior Convertible Notes 7/29/2015
Radius Health (RDUS) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 7/29/2015
Tauriga Sciences Inc. (TAUG) Stockholders Approve Increase In Authorized Common Stock 7/29/2015
Egalet Announces Pricing Of Public Offering Of Common Stock 7/29/2015
XlerateHealth Accelerator Announces Incoming Third Cohort 7/29/2015
Sanofi Genzyme (SNY) Launches Fifth Annual Patient Advocacy Leadership (PAL) Awards Program 7/29/2015
Becton, Dickinson and Company (BDX) Board Declares Dividend 7/29/2015
Neos Therapeutics Announces Closing Of Initial Public Offering And Exercise Of Underwriters’ Over-Allotment Option 7/29/2015
Baxalta Board Of Directors Declares Inaugural Dividend; Approves $1 Billion Share Repurchase Authorization 7/29/2015
Corbus Announces Call Notice For Exercise Of Warrants 7/29/2015
McKesson Corporation Announces Preliminary Voting Results From 2015 Annual Stockholder Meeting 7/29/2015
Amgen (AMGN) Announces 2015 Third Quarter Dividend 7/29/2015
BioPharm Executive: Why Some Drugmakers May See Their Profits Slashed 7/29/2015
Bacterin Prices $65 Million Of 6.00% Convertible Senior Notes 7/28/2015
Cara Therapeutics, Inc. (CARA) Announces Proposed Offering Of Common Stock 7/28/2015
Anatara Lifesciences Closes Heavily Subscribed Share Purchase Plan 7/28/2015
Dynavax Technologies Corporation (DVAX) Announces Exercise In Full Of Over-Allotment Option And Completion Of Public Offering Of Common Stock 7/28/2015



//-->